Characteristics of Clinically Significant Hyperplastic Polyps: Distinctions Between Microvesicular and Goblet Cell‐Rich Types
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.16921 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Osamu Toyoshima und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology, Toyoshima Endoscopy Clinic, Tokyo, Japan. Hauptthemen laut MEDLINE: Colonic Polyps, Goblet Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
Clinically significant serrated polyps (CSSPs) are defined as sessile serrated lesions (SSLs), SSLs with dysplasia, traditional serrated adenomas (TSAs), hyperplastic polyps (HPs) ≥ 10 mm, and HPs ≥ 6 mm in the proximal colon. HPs are further classified as microvesicular HPs (MVHPs) and goblet cell‐rich HPs (GCHPs). Among CSSPs, HPs were categorized into clinically significant MVHPs (CS‐MVHPs) and clinically significant GCHPs (CS‐GCHPs). This study compares the characteristics of CS‐MVHPs, CS‐GCHPs, and SSLs.
Methods
This study included patients who underwent colonoscopy at the Toyoshima Endoscopy Clinic between March 2021 and April 2024. Lesions diagnosed as adenomas or CSSPs were removed. Age, sex, number of polyps, detection rate, and polyp size were compared among CS‐MVHPs, CS‐GCHPs, and SSLs.
Results
In total, 14 065 patients were enrolled. The detection rates for CS‐MVHPs, CS‐GCHPs, and SSLs were 5.24%, 1.22%, and 6.36%, respectively. Patients with CS‐MVHPs or SSLs were significantly younger and more often female than those with CS‐GCHPs. The mean sizes of CS‐MVHPs and SSLs were significantly larger than that of CS‐GCHPs. The detection rate of CS‐GCHPs increased with age, whereas the detection rates of CS‐MVHPs and SSLs did not show a similar trend.
Conclusions
Compared with CS‐GCHPs, CS‐MVHPs were larger, more frequent, and more likely to be found in younger patients and females. The characteristics of CS‐MVHPs are similar to those of SSLs, supporting the hypothesis that CS‐MVHPs are precursors of SSLs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology, Toyoshima Endoscopy Clinic, Tokyo, Japan.
- Department of Gastroenterology and Hepatology, International University of Health and Welfare Narita Hospital, Chiba, Japan.
- Department of Gastroenterology, The University of Tokyo, Tokyo, Japan.
- Pathology and Cytology Laboratory Japan, Tokyo, Japan.
- Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.
ORCID-Profile: Osamu Toyoshima, Toshihiro Nishizawa
Zitieren
APA
Toyoshima, O., Nishizawa, T., Yoshida, S., Arano, T., Watanabe, H., Mizutani, H., Yamada, T., Takatori, Y., Ebinuma, H., & Saito, Y. (2025). Characteristics of Clinically Significant Hyperplastic Polyps: Distinctions Between Microvesicular and Goblet Cell‐Rich Types. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16921
Vancouver
Toyoshima O, Nishizawa T, Yoshida S, Arano T, Watanabe H, Mizutani H, et al. Characteristics of Clinically Significant Hyperplastic Polyps: Distinctions Between Microvesicular and Goblet Cell‐Rich Types. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16921
BibTeX
@article{Toyoshima2025,
author = {Toyoshima, Osamu and Nishizawa, Toshihiro and Yoshida, Shuntaro and Arano, Toru and Watanabe, Hidenobu and Mizutani, Hiroya and Yamada, Tomoharu and Takatori, Yusaku and Ebinuma, Hirotoshi and Saito, Yutaka},
title = {Characteristics of Clinically Significant Hyperplastic Polyps: Distinctions Between Microvesicular and Goblet Cell‐Rich Types},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.16921}
}
EUVIMED